Hematología y Hemoterapia

Resultados: 468
Tipo Título / Nombre Autor(es) Año
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia Simoes C, Chillon MC, Martínez-Cuadrón D, Calasanz MJ..., Bergua Burgués JM 2023
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C..., Burgues JMB, et al 2023
Mezigdomide (CC-92480), a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD), Combined with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Dose-Expansion Phase of the CC-92480-MM-001 Trial Richardson PG, Trudel S, Quach H, Popat R..., Casas Avilés I 2022
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Interim Analysis of the PCR-LMA Protocol of the Pethema Group Boluda B, Sargas C, Ayala R..., Bergua J 2022
Prognostic Impact of NPM1 and FLT3-ITD Mutations in Patients Treated with Non-Intensive Regimens: A Pethema Registry Study Suárez E, Alonso JM, Boluda B..., Bergua J 2022
Transcriptional and Genomic Characterization of Measurable Residual Disease (MRD) Cells in Acute Myeloid Leukemia (AML) Simoes C, Villar S, Ariceta B..., Bergua J 2022
Pethema NGS-AML Project. Final Analysis and Clinical Validation of New Genomic Classifications Sargas C, Ayala R, Larryoz MJ..., Bergua J 2022
Evolution of the Genetic and Biological Studies Performed at Diagnosis in Patients with Acute Myeloid Leukemia Included in the Pethema Epidemiological Registry (REALMOL Study) Labrador J, Martinez-Cuadron D, Boluda B..., Bergua J 2022
Concentración de hemoglobina reticulocitaria y ferroterapia en la ERC Deira J, García de la Vega C, Davín E, Arcos MJ 2022
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients Villar S, Ariceta B, Agirre X, Urribarri AD, Ayala R..., Bergua JM, et al 2022